PR Newswire Clinical TrialsOriginal article
ARPA-H Selects UpDoc to Lead Development of Autonomous Clinical AI System, in an Initiative Joined by Microsoft, OpenAI and NVIDIA
PartnershipAutonomous Clinical AI SystemPositive
AI Analysis
Summary
UpDoc received up to $9.2 million in ARPA-H ADVOCATE program funding to develop an autonomous clinical AI system for cardiovascular disease, partnering with Microsoft, OpenAI, and NVIDIA toward future FDA authorization and real-world deployment.
Outcome Details
UpDoc awarded up to $9.2 million under ARPA-H's ADVOCATE program to develop and validate an autonomous clinical AI system intended for future FDA authorization
Importance:6/10
Sentiment:
0.70
AIautonomous systemsFDA authorizationcardiovascular diseasepartnershipARPA-H funding
Read the original article
Published by PR Newswire Clinical Trials on September 9, 2026 5:00 PM